Vitamin C Treatment Rescues Prelamin A-Induced Premature Senescence of Subchondral Bone Mesenchymal Stem Cells
Open Access
- 3 April 2020
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2020, 1-16
Abstract
Aging is a predominant risk factor for many chronic conditions. Stem cell dysfunction plays a pivotal role in the aging process. Prelamin A, an abnormal processed form of the nuclear lamina protein lamin A, has been reported to trigger premature senescence. However, the mechanism driving stem cell dysfunction is still unclear. In this study, we found that while passaging subchondral bone mesenchymal stem cells (SCB-MSCs) in vitro, prelamin A accumulation occurred concomitantly with an increase in senescence-associated β-galactosidase (SA-β-Gal) expression. Unlike their counterparts, SCB-MSCs with prelamin A overexpression (MSC/PLA) demonstrated decreased proliferation, osteogenesis, and adipogenesis but increased production of inflammatory factors. In a hind-limb ischemia model, MSC/PLA also exhibited compromised therapy effect. Further investigation showed that exogenous prelamin A triggered abnormal nuclear morphology, DNA and shelterin complex damage, cell cycle retardation, and eventually cell senescence. Changes in gene expression profile were also verified by microarray assay. Interestingly, we found that ascorbic acid or vitamin C (VC) treatment could inhibit prelamin A expression in MSC/PLA and partially reverse the premature aging in MSC/PLA, with reduced secretion of inflammatory factors and cell cycle arrest and resistance to apoptosis. Importantly, after VC treatment, MSC/PLA showed enhanced therapy effect in the hind-limb ischemia model. In conclusion, prelamin A can accelerate SCB-MSC premature senescence by inducing DNA damage. VC can be a potential therapeutic reagent for prelamin A-induced aging defects in MSCs.Keywords
Funding Information
- Military Key Projects (BWS12J051)
This publication has 56 references indexed in Scilit:
- In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemiaJournal of Translational Medicine, 2019
- Senescent intimal foam cells are deleterious at all stages of atherosclerosisScience, 2016
- Vitamin C alleviates aging defects in a stem cell model for Werner syndromeProtein & Cell, 2016
- Aging Mesenchymal Stem Cells Fail to Protect Because of Impaired Migration and Antiinflammatory ResponseAmerican Journal of Respiratory and Critical Care Medicine, 2014
- The Hallmarks of AgingCell, 2013
- Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and MetastasisPLOS ONE, 2012
- Pot1 inactivation leads to rampant telomere resection and loss in one cell cycleNucleic Acids Research, 2010
- Functional Mesenchymal Stem Cells Derived From Human Induced Pluripotent Stem Cells Attenuate Limb Ischemia in MiceCirculation, 2010
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretionNature Cell Biology, 2009
- Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53Oncogene, 1999